Stroke 20 20: Implementation goals for intravenous thrombolysis
نویسندگان
چکیده
منابع مشابه
Intravenous Thrombolysis for Acute Ischemic Stroke due to Cardiac Myxoma; A Case Report
Myxoma may cause systemic embolization and frequently presents as ischemic stroke. There has been debates whether it is safe to use recombinant tissue plasminogen activator (rt-PA) in patients with cardiac myxoma who are presented with ischemic stroke at emergency department. we describe a young case of atrial myxoma with initial presentation of acute cerebral infarction symptoms who was treate...
متن کاملUltra-Early Intravenous Stroke Thrombolysis
In acute stroke care, time is brain, and the earlier thrombolysis is given the better the final functional outcome is. Our recently published single-center analysis showed robust benefit of ultra-early compared with later thrombolysis in terms of better outcome and lower mortality, outcomes supported by the most recently published pooled analysis. In our study, we identified 10% of patients wit...
متن کاملIntravenous thrombolysis for acute ischemic stroke.
Intravenous thrombolysis (IVT) with alteplase remains the standard treatment for acute ischemic stroke. Although IVT can be started up to 4.5 hours after symptoms' onset, it is all the more effective and safe when started early. It allows a 10% absolute reduction in the risk of handicap or death at 3 months, despite a 2-7% risk of symptomatic intracranial hemorrhage. Current research efforts in...
متن کاملRepeated Intravenous Thrombolysis for Early Recurrent Stroke
Intravenous thrombolysis (IVT) with tissue-type plasminogen activator demonstrated efficacy and safety for the treatment of acute ischemic stroke for almost 20 years. Nevertheless, IVT is still underutilized. A multitude of exclusion criteria reflects the fear for intracranial hemorrhage (ICH) and limits the widespread use of IVT. However, in recent years, several registry-based studies showed ...
متن کاملIntravenous thrombolysis in nonagenarians with ischemic stroke.
BACKGROUND AND PURPOSE Demographic changes will result in a rapid increase of patients age ≥90 years (nonagenarians), but little is known about outcomes in these patients after intravenous thrombolysis (IVT) for acute ischemic stroke. We aimed to assess safety and functional outcome in nonagenarians treated with IVT and to compare the outcomes with those of patients age 80 to 89 years (octogena...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Stroke Journal
سال: 2021
ISSN: 2396-9873,2396-9881
DOI: 10.1177/23969873211007684